Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.

Authors	Qiuyu Li, Cheng Cui, Fei Xu, Jianping Zhao, Nan Li, Haichao Li, Tianbing Wang, Hua Zhang, Na Liu, Yudong Wei, Xiaoye Niu, Yan Xu, Jianping Dong, Xueting Yao, Xiaohong Wang, Yahong Chen, Haiyan Li, Chunli Song, Jie Qiao, Dongyang Liu, Ning Shen
Journal	Science China. Life sciences (Sci China Life Sci) Vol. 64 Issue 4 Pg. 660-663 (04 2021) ISSN: 1869-1889 [Electronic] China
PMID	33471276 (Publication Type: Letter, Comment)
Chemical References	Antiviral Agents Hydroxychloroquine Chloroquine
Topics	Antiviral Agents (therapeutic use) Chloroquine (adverse effects) Humans Hydroxychloroquine (adverse effects) Pneumonia SARS-CoV-2 COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!